Natural bioactive gel to treat peri-implantitis around dental implants.
Official title: Efficacy of a Natural Bioactive Gel as an Adjunct to Standard Therapy in the Treatment of Peri-Implantitis: A Randomized Controlled Split-Mouth Clinical Trial
Run by University of Pavia · NCT07088679 · Data updated 2026-11-12
This study will try adding a natural bioactive gel (Sterify Gel®) to standard non-surgical cleaning to see if adults with peri-implantitis have less inflammation and bone loss around their implants.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | University of Pavia Academic / other |
| Locations | 1 site (Pavia, Lombardy) |
| Status | Recruiting |
| Started | July 30, 2025 |
| Main results expected | December 1, 2026 |
| Study ends | December 15, 2026 |
| Registry record updated | July 9, 2026 |
| Trial ID | NCT07088679 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–70 with peri-implantitis involving at least two dental implants in different quadrants, clinical signs of bleeding and/or suppuration on probing, and increased probing depth and radiographic bone loss who can attend follow-up visits are ideal candidates.
✕Probably not a fit
Patients with only one affected implant, those with excluded conditions (such as implanted electronic devices, uncontrolled systemic or autoimmune diseases, pregnancy or lactation), or those unable to comply with follow-up visits may not be eligible or likely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a randomized, controlled, split-mouth clinical trial in which each participant serves as their own control: one affected implant will receive standard non-surgical therapy plus a mucoadhesive bioactive gel (Sterify Gel®) and a second implant will receive standard therapy alone. The gel contains polyvinyl polymers, hydroxytyrosol, magnesium ascorbyl phosphate, and the antimicrobial peptide nisin and is applied as an adjunct to mechanical debridement and air-polishing. Twenty patients with at least two implants in different quadrants affected by peri-implantitis will be enrolled and followed for nine months. Clinical outcomes will include plaque levels, bleeding on probing, probing depth, and radiographic measures of bone loss.
Why it matters
Potential benefit: If successful, adding Sterify Gel® could reduce inflammation and pocket depth around implants and help limit further bone loss, potentially lowering the need for more invasive treatments.
How similar studies have gone: Local antimicrobial and bioactive adjuncts for peri-implant and periodontal disease have shown mixed but sometimes promising results in prior studies, while clinical data specific to Sterify Gel® are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients aged between 18 and 70 years * Presence of peri-implantitis involving at least two dental implants located in different quadrants * Presence of bleeding and/or suppuration on probing * Increased probing depth (PD) and radiographic bone loss compared to previous examinations * In the absence of previous clinical data: PD ≥ 6 mm and bone loss ≥ 3 mm apically from the coronal portion of the intraosseous implant area (radiographically assessed) * Willingness and ability to comply with study protocol and follow-up visits * Written informed consent provided Exclusion Criteria: * Patients with cardiac pacemakers or other implanted electronic devices * Neurological or psychiatric disorders that may interfere with study participation * Systemic diseases, metabolic disorders, or autoimmune conditions * Pregnancy or lactation Current participation in other clinical trials
Where it's running
-
Unit of Orthodontics and Pediatric Dentistry - Section of Dentistry - Department of Clinical, Surgical, Diagnostic and Pediatrics - University of Pavia
Pavia, Lombardy, Italy Recruiting
Study contacts
- Principal investigator: Andrea Scribante, Associate Professor — University of Pavia
- Study coordinator: Andrea Scribante, Associate Professor
- Email: andrea.scribante@unipv.it
- Phone: +39 0382516223
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Minimally invasive non-surgical treatment for peri-implantitis
This test compares a gentler, minimally invasive non-surgical cleaning (MINST) with standard non-surgical cleaning for adults who have peri-implantitis to see which gives better gum, bone, and patient-reported outcomes over 12 months.
-
Graftless Periosteal Coverage vs Xenogenic Graft for Jumping Gap in Immediate Mandibular Molar Implants
This study tests whether graftless periosteal coverage can perform as well as a xenogenic bone graft beneath a collagen membrane for managing a jumping gap in immediate mandibular molar implants.
-
Accuracy of the Calibrated Framework for Full-Arch Implant Impressions in Edentulous Patients
This study tests whether digital scanning with a calibrated framework can match the accuracy of traditional splinted impressions for full-arch dental implants in completely toothless patients.
-
Passive Fit of Implant-Supported Frameworks Using Digital vs Conventional Impressions
This study tests whether three impression methods can produce a passively fitting full-arch mandibular implant framework for edentulous patients.
-
How Smoking Affects Immune Responses Around Dental Implants
This study tests how smoking changes the body's immune response around dental implants in people with healthy implants, peri-implant mucositis, or peri-implantitis.
-
AmbiJet-assisted treatment for inflamed dental implants
This study tests whether applying cold atmospheric plasma with the AmbiJet system after standard cleaning helps reduce inflammation around dental implants more quickly in adults with peri-implant mucositis or peri-implantitis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.